Headlines

Palliative Cancer Care Should Focus on Symptoms, Not Diagnoses

Palliative Cancer Care Should Focus on Symptoms, Not Diagnoses

Results of a cross-sectional study determined that symptoms and care needs dictate palliative care needs of patients with cancer.

COX-2 Inhibitors Can Improve Response to Immunotherapy of Some Cancer Tumors

COX-2 Inhibitors Can Improve Response to Immunotherapy of Some Cancer Tumors

Tumors that express the protein IDO1 constitutively respond to the COX-2 inhibitor celecoxib and have increased infiltration of certain T-cell subsets, making them more responsive to anti-PD1 treatment.

Risk for Prostate Cancer Not Associated With Vasectomy, Meta-analysis Affirms

Risk for Prostate Cancer Not Associated With Vasectomy, Meta-analysis Affirms

Meta-analysis of data from more than 50 studies reaffirms that vasectomy is not associated with increased risk of prostate cancer.

Disease-Free Survival After Breast Cancer Comparable With Exemestane, Sequential Tamoxifen/Exemestane

Disease-Free Survival After Breast Cancer Comparable With Exemestane, Sequential Tamoxifen/Exemestane

A 10-year follow-up study finds disease-free survival (DFS) comparable with exemestane and sequential tamoxifen/exemestane in patients with HR-positive breast cancer.

Oropharyngeal Mucositis Pain Effectively Relieved With Indomethacin Oral Spray

Oropharyngeal Mucositis Pain Effectively Relieved With Indomethacin Oral Spray

Indomethacin oral spray (IM-OS) is proven to be a safe and effective treatment for oropharyngeal mucositis pain in patients with cancer.

Incidence of Invasive Cervical Cancer May Not Be Affected by HIV Status

Incidence of Invasive Cervical Cancer May Not Be Affected by HIV Status

HIV infection may not have a contributory effect on the incidence of invasive cervical cancer (ICC) in women as they age.

Vitamin D3 Supplementation Has No Impact on Breast Density Percentage, Breast Cancer Risk

Vitamin D3 Supplementation Has No Impact on Breast Density Percentage, Breast Cancer Risk

Supplementation with vitamin D3 in premenopausal women does not have a significant effect on breast density percentage, nor does it reduce breast cancer risk.

Ixazomib, a New PI, Offers Improved Efficacy With Acceptable Toxicity Profile for Relapsed/Refractory Multiple Myeloma

Ixazomib, a New PI, Offers Improved Efficacy With Acceptable Toxicity Profile for Relapsed/Refractory Multiple Myeloma

Ixazomib, a new proteasome inhibitor (PI), is a third option for the treatment of relapsed/refractory multiple myeloma (RRMM) offering the potential of improved efficacy and the convenience of oral therapy.

Acupuncture May Improve Fatigue in Patients with Lung Cancer

Acupuncture May Improve Fatigue in Patients with Lung Cancer

Acupuncture was found to improve cancer-related fatigue in patients with lung cancer in as little as 2 weeks, according to results of a double-blind randomized clinical study.

A Review of CDK4/6 Toxicities and Interactions Management in Breast Cancer

A Review of CDK4/6 Toxicities and Interactions Management in Breast Cancer

CDK4/6 inhibitors, which block the activity of regulatory enzymes, are tolerated fairly well in patients with cancer; however, oncology nurses should be aware of some strategies that minimize their adverse effects.

Conference Coverage

Wait Times From Cancer Diagnosis to First Treatment Longer, Negative Impact on Survival

Data from the National Cancer Database are indicating that wait times from cancer diagnosis to initial treatment were substantially longer over a 5-year period.

Adding Pertuzumab to Adjuvant Therapy Is Beneficial for Some Women with Early Breast Cancer

Adding a second HER2-blocker to standard care therapy after surgery for HER2-positive breast cancer may be modestly beneficial for some women.

Superior Tolerability, Efficacy With Alectinib in Treatment-Naïve ALK-poistive NSCLC

Phase 3 clinical trial results show fewer adverse effects and longer survival with alectinib compared with crizotinib in patients with treatment-naïve ALK-positive NSCLC.

Significance of Prostate Cancer Treatment-Related Factors Differ in Black, White Men

A survey of men with prostate cancer revealed that treatment-related factors impact treatment decisions differently in black men compared with white men.

Survivorship Care Plans: Providing A Blueprint for Health Care After Cancer

Survivorship care plans can ensure that cancer survivors know their cancer and treatment history, and are equipped to maintain proper follow-up care.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs